These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24782046)

  • 1. Interleukin 6 and cognitive dysfunction.
    Trapero I; Cauli O
    Metab Brain Dis; 2014 Sep; 29(3):593-608. PubMed ID: 24782046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.
    Lotrich FE; Butters MA; Aizenstein H; Marron MM; Reynolds CF; Gildengers AG
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):635-44. PubMed ID: 24273017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
    Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
    Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study.
    Economos A; Wright CB; Moon YP; Rundek T; Rabbani L; Paik MC; Sacco RL; Elkind MS
    Neuroepidemiology; 2013; 40(4):253-9. PubMed ID: 23364322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production of inflammatory cytokines in mild cognitive impairment.
    Magaki S; Mueller C; Dickson C; Kirsch W
    Exp Gerontol; 2007 Mar; 42(3):233-40. PubMed ID: 17085001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and C-Reactive Protein Levels and 9-Year Cognitive Decline in Community-Dwelling Older Women: The Women's Health and Aging Study II.
    Palta P; Xue QL; Deal JA; Fried LP; Walston JD; Carlson MC
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):873-8. PubMed ID: 25161214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and rate of cognitive change in high-functioning older adults.
    Alley DE; Crimmins EM; Karlamangla A; Hu P; Seeman TE
    J Gerontol A Biol Sci Med Sci; 2008 Jan; 63(1):50-5. PubMed ID: 18245760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus.
    Tay SH; Mak A
    Int J Mol Sci; 2015 May; 16(5):10281-300. PubMed ID: 25955648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
    Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
    Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers.
    Marsland AL; Petersen KL; Sathanoori R; Muldoon MF; Neumann SA; Ryan C; Flory JD; Manuck SB
    Psychosom Med; 2006; 68(6):895-903. PubMed ID: 17132839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Central nervous system involvement in connective tissue diseases].
    Hirohata S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):109-17. PubMed ID: 15291247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential expressions of serum cytokines in cognitive dysfunction patients after colorectal surgery].
    Zhang Y; Qian Y; Si Y; Bao H; Zhou J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):231-4. PubMed ID: 25652866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.
    Griffin ÉW; Skelly DT; Murray CL; Cunningham C
    J Neurosci; 2013 Sep; 33(38):15248-58. PubMed ID: 24048854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients.
    Kozora E; Laudenslager M; Lemieux A; West SG
    J Int Neuropsychol Soc; 2001 Sep; 7(6):745-54. PubMed ID: 11575596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
    Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
    Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and pathological roles of interleukin-6 in the central nervous system.
    Gruol DL; Nelson TE
    Mol Neurobiol; 1997 Dec; 15(3):307-39. PubMed ID: 9457704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
    Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
    Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.